The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Psychemedics Corporation Completes Stock Repurchase Agreement with 3K Limited Partnership
Dec 11, 2024•over 1 year ago
Contract Type
agreement
ActonPublishingNews
Description
On December 10, 2024, Psychemedics Corporation finalized a stock repurchase agreement with 3K Limited Partnership and other associated trusts. The agreement involved the acquisition of shares at a purchase price of $2.35 per share, facilitating the acquisition of all fractional share interests resulting from a reverse stock split. Additionally, 3K Limited Partnership provided funds for working capital requirements and general corporate purposes.
Company Information
Company
Psychemedics Corporation
Location
Acton, Massachusetts, United States
About
Psychemedics (NASDAQ: PMD) develops and delivers the world’s leading hair drug test for detecting drugs of abuse. Some of the most well-known companies in the Fortune 500, largest police departments and schools across the country use Psychemedics’ patented drug tests using hair to ensure safer workplaces and campuses. After 30 years, the company remains the drug testing industry’s leading innovator and consistently advances the science of hair testing for drugs of abuse.
ActonPublishingNews